Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Heliyon|May 30, 2023
A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIIIAtul Rawal, Christopher Kidchob, Jiayi Ou, et al.
The AAPS Journal|August 4, 2019
TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein ImmunogenicityOsman N Yogurtcu, Zuben E Sauna, Joseph R McGill, et al.
The AAPS Journal|October 9, 2025
Physiologically Based Pharmacokinetic Modeling and Simulation in Regulatory Review: US FDA CBER Experience and PerspectivesMillion A Tegenge, Osman N Yogurtcu, Artur A Belov, et al.
Transfusion|April 3, 2019
Predictive model for Zika virus RNA minipool nucleic acid testing in outbreak scenariosOsman N Yogurtcu, Hong Yang, Caren Chancey, et al.
NPJ Vaccines|February 5, 2026
Quantitative benefit risk analysis for prophylactic vaccines in the context of FDAs benefit risk frameworkHong Yang, Osman N Yogurtcu, Ujwani Nukala, et al.
The Journal of Chemical Physics|October 3, 2019
An implicit lipid model for efficient reaction-diffusion simulations of protein binding to surfaces of arbitrary topologyYiben Fu, Osman N Yogurtcu, Ruchita Kothari, et al.
Mathematical Medicine and Biology : a Journal of the IMA|February 26, 2024
Dosage optimization for reducing tumor burden using a phenotype-structured population model with a drug-resistance continuumLifeng Han, Osman N Yogurtcu, Marisabel Rodriguez Messan, et al.
Vaccine|April 4, 2022
Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 yearsPatrick R Funk, Osman N Yogurtcu, Richard A Forshee, et al.
Vaccine: X|June 16, 2023
Benefit-risk assessment of Covid-19 vaccine, MRNA (MRNA-1273) for males age 18-64 yearsOsman N Yogurtcu, Patrick R Funk, Richard A Forshee, et al.
Plos Computational Biology|September 24, 2021
Mathematical model of a personalized neoantigen cancer vaccine and the human immune systemMarisabel Rodriguez Messan, Osman N Yogurtcu, Joseph R McGill, et al.
Pageof 3